---
title: "Imatinib - Hypereosinophilic syndrome"
sidebar: mydoc_sidebar
permalink: db00619-mesh-d017681-1.html
toc: false 
---


Path ID: `DB00619_MESH_D017681_1`
{% include image.html url="images/db00619-mesh-d017681-1.png" file="db00619-mesh-d017681-1.png" alt="db00619-mesh-d017681-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000068877 | imatinib | Drug |
| MESH:D015514 | Oncogene Proteins, Fusion | GeneFamily |
| UniProt:P16234 | Platelet-derived growth factor receptor alpha | Protein |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| HP:0001880 | Eosinophilia | PhenotypicFeature |
| MESH:D017681 | Hypereosinophilic Syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Imatinib | DECREASES ACTIVITY OF | Oncogene Proteins, Fusion |
| Oncogene Proteins, Fusion | DERIVES FROM | Platelet-Derived Growth Factor Receptor Alpha |
| Platelet-Derived Growth Factor Receptor Alpha | POSITIVELY REGULATES | Cell Population Proliferation |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Eosinophilia |
| Eosinophilia | MANIFESTATION OF | Hypereosinophilic Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00619#mechanism-of-action](https://go.drugbank.com/drugs/DB00619#mechanism-of-action){:target="_blank"}